BridgeBio Expands U.S. Access to Rare Disease Medicines
PALO ALTO, Calif., August 31, 2026 BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on medicines for...
drug affordability
Advertisement
Zentiva Appeals EU Wastewater Directive Impact on Pharma
PRAGUE / BRUSSELS, April 27, 2026 Zentiva has filed an appeal before the Court of Justice of the European...
Merck–U.S. Agreement Redefines Drug Access and Pricing
RAHWAY, New Jersey, United States — December 19, 2025 — Merck & Co., known globally as MSD, has reached...
Gilead–U.S. Pact Aims to Cut Drug Costs for Americans
December 22, 2025 | Foster City, California — Gilead Sciences announced a three-year agreement with the U.S. Government designed...
BMS–U.S. Pact Expands Access to Eliquis for Americans
December 19, 2025 | Princeton, New Jersey — Bristol Myers Squibb announced a landmark agreement with the U.S. government...
Advertisement
